KYTX Latest Press Releases

-- October 23, 2026 --

Kyverna Therapeutics Highlights Promising Updated Clinical Data with Miv-cel in Progressive Multiple Sclerosis at MS Toronto 2026 Globe Newswire 10:30 AM

-- October 22, 2026 --

Did Kyverna Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PRNewswire 2:21 PM

-- October 21, 2026 --

Kyverna Therapeutics Presents Full One-Year Registrational Data Set Demonstrating Sustained Clinical Benefit of Miv-cel in Stiff Person Syndrome at MS Toronto Globe Newswire 7:15 AM

-- October 7, 2026 --

Kyverna Therapeutics to Present Positive Data in Stiff Person Syndrome and Progressive Multiple Sclerosis at MSToronto2026 Globe Newswire 8:00 AM

-- September 24, 2026 --

Kyverna Therapeutics Reports Positive One-Year Data Demonstrating Durable Clinical Responses and Favorable Safety Profile for Miv-cel in Stiff Person Syndrome and Generalized Myasthenia Gravis Globe Newswire 6:00 AM

-- September 2, 2026 --

Kyverna Therapeutics to Present at Upcoming Investor Conferences Globe Newswire 4:05 PM

-- August 11, 2026 --

Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results Globe Newswire 4:02 PM

-- July 27, 2026 --

Kyverna Therapeutics and ElevateBio Enter into Commercial Manufacturing and Supply Agreement for Miv-cel Globe Newswire 8:00 AM

-- June 22, 2026 --

Kyverna Therapeutics Appoints Ritesh Srivastava as Chief Legal and Compliance Officer, Adding Leadership Strength to Support Commercial-Stage Transition Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes